Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Cellbricks logo — Cellbricks envisions a future where 3D-bioprinting of human...

Cellbricks

Cellbricks envisions a future where 3D-bioprinting of human tissue and organs is a common medical practice

Founded 2016 Germany Berlin, Germany 26 employees Series Unknown Biotechnology, Life Sciences +2

General Information

Company Name Cellbricks
Founded Year 2016
Location Germany Berlin, Germany +1
Founders / Decision Makers
Team member
Employees 26
Industries Biotechnology, Life Sciences, Manufacturing +1
Funding Stage Series Unknown
Social

Get notified when Cellbricks moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Cellbricks

Cellbricks, founded in 2016, is a promising player at the intersection of Biotechnology, Life Sciences, Manufacturing, and 3D Printing. The company is headquartered in Germany, specifically in Berlin, a city renowned for its vibrant startup culture.

The company’s mission is encapsulated in its slogan: "Cellbricks envisions a future where 3D-bioprinting of human tissue and organs is a common medical practice". Leveraging proprietary biofabrication technology, Cellbricks aims to revolutionize the medical field by bioprinting tissue therapeutics that can greatly enhance organ function, offering potential breakthroughs for millions of patients worldwide.

The startup completed its latest Venture Round investment on 31 December 2022, backed by Brooks Hill Partners. The company boasts a diverse, highly skilled team of experts, unified by a commitment to improve healthcare outcomes.

Taxonomy: 3D-bioprinting, Bioprinting, Biofabrication, Synthetic Biology, Tissue Engineering, Regenerative Medicine, Tissue Therapeutics, Organ Printing, HealthTech, Recombinant Collagen, Autologous Tissue Implants, Pharmaceuticals, Lab Models, Breast Reconstruction

Services & Products

Development of Cell-based Human Tissue Therapeutics
Biofabrication of Human Tissues
AI-driven Tissue Engineering Solutions
Production of Scalable and Functional Tissues for Medical Use

Target Customers

Healthcare Providers Medical Researchers Biotechnological Companies Patients with Tissue Dysfunction

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• 1
Investor
31 Dec 2022
Seed Round •••••• 1
Investor
05 Sep 2019

Cellbricks Alternatives & Competitors

View All Alternatives
Cellbricks vs
Bonus Biogroup
Bonus Biogroup Israel

Innovation ★ Tissue Engineering ★ Cell Therapy ★ Impact

47 employees
Biotechnology, Health Care
Compare Cellbricks vs Bonus Biogroup
Cellbricks vs
OneLegacy
OneLegacy United States

Saving and healing lives through organ, eye and tissue donation

361 employees
Cellbricks vs
Indiana Donor Network
Indiana Donor Network United States

Saving lives through organ, tissue and eye donation.

238 employees
Health Care, Health and Wellness
Compare Cellbricks vs Indiana Donor Network
Also compare with: Cellbricks vs Harvard Apparatus Regenerative Technology, Inc. Harvard Apparatus Regenerative Technology, Inc. View all alternatives

FAQ About Cellbricks

Cellbricks envisions a future where 3D-bioprinting of human tissue and organs is a common medical practice
Cellbricks was founded in 2016.
Cellbricks is headquartered in Berlin, Germany.
Cellbricks operates in the following industries: Biotechnology, Life Sciences, Manufacturing, 3D Printing.
Cellbricks has approximately 26 employees.
Cellbricks has completed 2 funding rounds. The latest funding stage is Series Unknown.
Cellbricks offers: Development of Cell-based Human Tissue Therapeutics, Biofabrication of Human Tissues, AI-driven Tissue Engineering Solutions, Production of Scalable and Functional Tissues for Medical Use.
Top alternatives and competitors to Cellbricks include Bonus Biogroup, OneLegacy, Indiana Donor Network, Harvard Apparatus Regenerative Technology, Inc., Mississippi Organ Recovery Agency. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Cellbricks and Bonus Biogroup are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Cellbricks and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy